Why EU Regulations Are Changing The Face Of Innovation And May Be Unsustainable
The EU must keep its medtech regulation under review as rapidly changing technology and external market factors may be challenging the operability of some aspects of the new medtech regulations, especially for less mature businesses and SMEs. Legal medtech expert, Shuna Mason, of CMS explains why.
You may also be interested in...
With so many regulatory developments happening concurrently in the EU at present, five forthcoming conferences promise delegates a timely update and vibrant discussions.
With so much discussion now on the need for fundamental change in the future regulation of medtech products in the EU, Medtech Insight reflects on lessons to be learnt.
The EU medtech industry is calling for an update to the decades-old rules on electronic IFU for devices. A glimpse at the listings in the European Commission’s recently released table of member state language requirements reflects how punitive the demand for hard-copy IFU can be.